Φορτώνει......
Topical application of the tumour necrosis factor‐α antibody infliximab improves healing of chronic wounds
The role of tumour necrosis factor‐alpha (TNF‐α) in wound healing is not clear. Elevated levels of TNF‐α have been observed in fluids from chronic wounds and have been shown to decrease over time during the healing process. Therapeutic antibodies such as infliximab can inhibit TNF‐α activity. In thi...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Int Wound J |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Blackwell Publishing Ltd
2006
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7951247/ https://ncbi.nlm.nih.gov/pubmed/16984574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1742-481X.2006.00233.x |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|